Teva Launches Generic Proscar
This article was originally published in The Pink Sheet Daily
Teva has 180-day exclusivity for its generic version of Merck's Proscar (finasteride), the generics firm announced June 19
You may also be interested in...
Dr. Reddy's will sell authorized generics of Zocor and Proscar upon expiration of their respective patents in June.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.